BioSpace News Archive

Paratek Pharmaceuticals, Inc. announced that on September 30, 2022, the Company granted stock options and restricted stock units to twenty new employees of the Company.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on October 1, 2022 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in September 2022.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its board of directors has set October 26, 2022 as the record date (Record Date) for the dividend of shares of common stock of OmniAb, Inc. to be distributed to Ligand shareholders in order to effect the separation of Ligand and OmniAb into two independent, publicly traded companies.

Viewpoint Molecular Targeting, Inc. announced that the U.S. Food and Drug Administration has granted fast track designation for the development of [212Pb]VMT-α-NET for treatment of patients with SSTR2-positive unresectable or metastatic neuroendocrine tumors.

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved the company’s retroviral vector (RVV) manufacturing facility in Oceanside, California, for commercial production.

Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a result of its Series A funding round.

Lohman Technologies announced , Dr. Nick Turkal, retired President and CEO, Advocate Aurora Health, has been named Chief Medical Advisor.

Boston, Massachusetts and Singapore, Singapore--(Newsfile Corp. - October 3, 2022) - AIM Biotech announced the launch of the organiX System

The global Bioinformatics market size is expected to be worth around USD 45.9 billion by 2030, according to a new report by Nova one advisor.

According to Nova one advisor, the global Collagen market size is expected to hit around USD 21.4 billion by 2030 from valued at USD 10.5 billion in 2021 and growing at a CAGR of 9.2% from 2022 to 2030.